Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genetic association study of childhood aggression across raters, instruments, and age

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Serotonin transporter availability increases in patients recovering from a depressive episode

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hot and Cold Cognitive Disturbances in Parkinson Patients Treated with DBS-STN: A Combined PET and Neuropsychological Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Family history of psychiatric disorders as a risk factor for maternal postpartum depression: a systematic review protocol

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. PET-BIDS, an extension to the brain imaging data structure for positron emission tomography

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

Previous studies have indicated that antidepressants that inhibit the serotonin transporter reduces oxidative stress. DNA and RNA damage from oxidation is involved in aging and a range of age-related pathophysiological processes. Here, we studied the urinary excretion of markers of DNA and RNA damage from oxidation, 8-oxodG and 8-oxoGuo, respectively, in the NeuroPharm cohort of 100 drug-free patients with unipolar depression and in 856 non-psychiatric community controls. Patients were subsequently treated for 8 weeks with escitalopram in flexible doses of 5-20 mg; seven of these switched to duloxetine by week 4, as allowed by the protocol. At week 8, 82 patients were followed up clinically and with measurements of 8-oxodG/8-oxoGuo. Contextual data were collected in patients, including markers of cortisol excretion and low-grade inflammation. The intervention was associated with a substantial reduction in both 8-oxodG/8-oxoGuo excretion (25% and 10%, respectively). The change was not significantly correlated to measures of clinical improvement. Both markers were strongly and negatively correlated to cortisol, as measured by the area under the curve for the full-day salivary cortisol excretion. Surprisingly, patients had similar levels of 8-oxodG excretion and lower levels of 8-oxoGuo excretion at baseline compared to the controls. We conclude that intervention with serotonin reuptake inhibitors in unipolar depression is associated with a reduction in systemic DNA and RNA damage from oxidation. To our knowledge, this to date the largest intervention study to characterize this phenomenon, and the first to include a marker of RNA oxidation.

OriginalsprogEngelsk
TidsskriftTranslational psychiatry
Vol/bind12
Udgave nummer1
Sider (fra-til)204
ISSN2158-3188
DOI
StatusUdgivet - 16 maj 2022

Bibliografisk note

© 2022. The Author(s).

ID: 78047998